O2-10-4Avelumab (MSB0010718C; anti-PD-L1), in Japanese patients with advanced gastric cancer: results from phase Ib trial

S. Hironaka,K. Shitara,S. Iwasa,T. Nishina,K. Muro,T. Esaki,T. Satoh,H. Hara,N. Machida,A. Heydebreck,A. Shimizu,T. Doi

Published 2016 in Annals of Oncology

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2016
Venue
Annals of Oncology
Publication date
2016-11-01
Fields of study
Medicine
Identifiers
DOI 10.1093/annonc/mdw521.047
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

Product review: avelumab, an anti-PD-L1 antibody
2018cites this paper